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ABSTRACT 
Adherence to non-occupational post-exposure prophylaxis (nPEP) among sexual 
violence (SV) victims and their retention in care after SV represent significant 
challenges. This study aimed at identifying predictors of adherence to nPEP and 
retention in clinical-laboratory follow-up among SV victims in São Paulo, Brazil. 
We conducted a retrospective cohort study of SV victims admitted to care and 
follow-up at the SV unit of the main reference hospital in São Paulo within 72 
hours following the SV episode. Eligible patients were submitted to a 
standardised protocol that included nPEP, screening and management for other 
STI as well as emergency contraception. Predictors of adherence to nPEP for 28 
days and retention in care until discharge at 180 days after admission were 
analysed. A total of 199 SV episodes in 197 victims were recorded from 
January/2001 to December/2013 (156 months). Of those episodes, 167 were 
eligible to receive nPEP and 160 (96%) actually received a prescription. Overall 
104/160 (65%, 95%CI 57-72%) SV victims, who received nPEP, were fully 
adherent to nPEP up to 28 days, whereas 89/199 (45%, 95%CI 38-52%) were 
retained in care for 180 days following admission. In multivariate analysis, 
patients undergoing at least one psychological consultation (n=126) were more 
likely to adhere to nPEP (adjusted OR 8.32; 95%CI 3.0-23.3) and to be retained in 
care for 6 months (adjOR 40.33; 95%CI 8.33-195.30) compared to patients not 
receiving psychological support.  In contrast, study outcomes were not 
associated with victims’ age and sex and with type of perpetrator. In our cohort 
provision of psychological care was shown to be associated with enhanced 






Sexual violence (SV) has been recognized as a public health problem by the 
World Health Organization since 19941. Because of the use of different 
definitions, estimates of its worldwide occurrence range between 2-62% for girls 
and 3-16% for boys2. Nearly 1 in 5 women (18.3%) and 1 in 71 men (1.4%) in 
the United States have been raped at some time in their lives3. In Brazil, the 
occurrence of SV is estimated to be between 300,000 to 500,000 per year4. 
Vulnerable groups include women, children and adolescents, people with a 
history of SV in childhood, individuals under the influence of alcohol and other 
substances, people with disabilities, those living in conflict areas and low-income 
individuals with limited access to education and protection by the legal system1-
6.  
In the past 20 years, the long-term effects of SV have been more 
thoroughly studied, particularly the physical and mental health lasting effects, 
although consequences of SV are not always proportional to the severity of the 
initial physical trauma experienced by victims. The level of emotional and 
physical violence or intimidation suffered during the SV episode, the sometimes 
recurrent nature of exposure, the role of multiple and/or known perpetrators, 
the early age of the victim, and finally the lack of emotional support provided 
after the episode, all have an important impact on the short and long-term 
outcomes of SV1. In this context, lifetime risk of STIs was shown higher after a SV 
episode7-12. Several intertwining factors could mediate risky sexual behavior 
among SV victims:  multiple sexual partners, inconsistent condom use, lack of 
access to STIs treatment, mental disorders (depression and anxiety), severity of 
alcohol and illicit drug abuse9-13.  
 
Care for SV victims requires a multi-disciplinary approach, including an 
assessment of emergency medical or surgical issues, such as trauma, screening 
and prevention of sexually transmitted infections (STI) including HIV, through 
the provision of non-occupational post-exposure prophylaxis (nPEP); provision 
of emergency contraception when applicable; and the provision of psychological 
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and social support14 -17. In 2000, a standardized protocol for SV victims was 
implemented at Hospital das Clinicas, a tertiary reference hospital of the Faculty 
of Medicine, University of São Paulo: this initiative has encouraged better 
identification and reporting of SV episodes by the medical emergency services. 
Globally, adherence to nPEP and retention in care among SV victims have been 
shown to be limited, ranging from 31,1% to 51,4 % 16,17. In Brazil, whilst nPEP is 
offered free of charge to eligible SV victims through the national Unified Health 
System, adherence to completion rarely exceeds 60%15-19. Moreover, there is no 
evidence of improvement in nPEP adherence among SV victims since this 
intervention was recommended. 
 
In this study, we investigated predictors of adherence to nPEP for 28 days 
and of retention in care up to 180 days after inclusion in a cohort of SV victims 




We conducted a retrospective cohort study (January 2001 to December 
2013), based on medical chart review of patients admitted to the SV unit of 
Hospital das Clinicas – a reference tertiary hospital located in the heart of 
metropolitan area of São Paulo, Brazil -within 72 hours following the SV episode. 
 
Patient and public involvement 
The experience we accumulated in the outpatient care of victims made us 
develop our research question. Defining predictors for adherence to HIV post-
exposure prophylaxis (nPEP) and to retention in care after a SV episode was 
considered a priority to optimize the outcomes of care.  The option for a 14-year 
review of medical charts was based on institutional data availability. The 
involvement of subjects in the study design or in recruitment of participants was 
unfeasible, due to the particular confidentiality issues that involve SV. 
Nevertheless, study results were shared with participants in feedback sessions to 





According to institutional guidelines, upon admission, SV victims are first 
interviewed and examined by a surgeon or a gynecologist, depending on the type 
and severity of trauma assessed at entry. Thereafter, they are referred to an 
infectious disease specialist for collection of detailed information about the SV 
episode and immediate prescription of nPEP and prophylaxis for other STIs. In 
addition, they undergo serological screening of HIV, hepatitis B and C, and 
syphilis (treponemal and non-treponemal tests), as well as emergency 
contraception if applicable. Genital (vaginal or male urethral) samples for 
gonoccocal and Chlamydia screening, though recommended in the guidelines, are 
not systematically collected due to inconsistent availability of laboratory 
consumables. 
 
HIV nPEP drugs included zidovudine/lamivudine and nelfinavir prior to 
2005 and lopinavir/ritonavir thereafter and was considered complete if taken 
for 28 days. Chemoprophylaxis for STIs includes prevention for trichomoniasis 
(single dose of oral metronidazole 2g); syphilis and gonorrhea (single dose of 
intramuscular ceftriaxone 1g); Chlamydia infection (single dose of oral 
azithromycin 1g); and hepatitis B virus (HBV) active and passive immunization. 
Emergency contraception is provided whenever penile-vaginal penetration is 
reported by female victims of fertile age. Screening results are checked at the 
first outpatient care visit no longer than 7 days after admission, for identification 
of existing/past STIs. Medication, laboratory tests and multidisciplinary clinical 
support are provided free of charge, following recommendations of the Brazilian 
Ministry of Health15. 
 
SV victims are then invited to return for follow-up visits on days 7, 30, 90 
and 180 after admission, for clinical and laboratory assessment of incident HIV 
infection and STIs. During follow-up, the comprehensive approach provided to 
victims and their families also involves nursing care as well as psychological and 
social worker support. This includes victims and non-offending caregivers 
counseling, enhanced adherence support to medical interventions by the nursing 
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staff, biweekly individual psychodynamic therapy sessions from 2 weeks after 
the SV episode, tailored according to age for children, adolescents or adults, and 
appointment with a social worker for assessment of social needs and judicial 
counseling. Victims are followed up for 180 days to assess seroconversion for 
HIV, hepatitis B and syphilis, regardless of duration of psychotherapy.  
 
For this study, data retrieved through medical chart review were 
transferred to a standardized electronic form (REDCap)20. The main outcomes 
variables were: (a) Adherence to nPEP reported at the follow-up visit on day 28; 
(b) Retention in care, defined as having been retested for HIV and syphilis on day 
180. Victims’ demographics, clinical aspects, characteristics of the SV episode, 
physical findings at admission and provision of psychological and social support 
were assessed as potential predictors of self-reported adherence to nPEP over 
the next 28 days, and of retention in care during the 180-day follow-up. 
Psychological support was defined as having attended at least one 
psychodynamic session, whereas social support was assessed by chart 
information about family or friend aid. 
 
Statistical analysis 
 Variables were described as frequencies with their respective 95% 
confidence intervals, medians and interquartile ranges (IQR) as appropriate. 
Comparisons were performed using Pearson’s chi-square test or Fisher’s exact 
test for categorical variables, Wilcoxon-Mann-Whitney rank-sum test for 
continuous variables, as appropriate. Risk ratios measuring the unadjusted 
association of potential predictors of adherence to nPEP and retention in care 
were calculated using tabular methods, along with their respective 95% 
confidence intervals (CI). For multivariate analysis, we fitted logistic regression 
models including variables selected based on causal diagrams and report odds-
ratios with their 95%CI. We considered a two-tailed alpha error of 0.05 
throughout the analysis, performed using Stata 15.1 (StataCorp College Station, 




 The research protocol was approved by the Institutional Review Board of 
Hospital das Clinicas (#0333/11). There was no requirement to ask for 
retrospective consent of SV victims since data of interest were retrieved from 
medical charts. Data transposed on CRFs were anonymized and confidentiality 




Overall, 505 SV victims were seen at the SV unit between January 2001 
and December 2013, of whom 251 (50%) were admitted within a 72-hour 
window period and eligible for this study. Medical charts were incomplete or 
unavailable for 52 (20.7%) SV episodes, leading to a final cohort of 199 SV 
episodes involving 197 individuals (2 women suffered a second SV episode) for 
analysis (Figure 1).  
 
SV victims were predominantly female (80%), white (75%), of median 
age 23 (IQR, 17-29) for females and 17 (IQR, 14-32) for males, and included 
mostly students (46%) or individuals employed in skilled labor (30%), with 
median schooling of 9 years (IQR, 6-11). Mental or physical disability was 
reported for five (3%) individuals (Table 1). Median time between the SV 




Overall, 167 of 199 SV episodes met eligibility criteria for nPEP, but only 
160 (96%) actually received this intervention (3 refusals; 4 did not receive a 
prescription) (Figure 1). All 199 SV episodes were included in the analysis of 
predictors of retention in care. 
 
 Forty victims were lost from follow-up before day 28, and 16 
discontinued nPEP due to misunderstanding of regimen dosage (13 cases) or 
side effects (3 cases). Among 160 nPEP users, at least one side effect was 
recorded for 127 cases (79.4%) and most often included nausea and vomiting 
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(31.5%), diarrhea (26.8%), neurological disturbances (11.8%) and skin rashes 
(2.4%). Because of side effects, nPEP regimen was modified for 7.1% (n=9) of 
victims over the course of treatment.  
 
 For 160/199 (85%) SV episodes, STI prophylaxis was prescribed, 
including ceftriaxone (85%), azithromycin (81%) and metronidazole (76%). 
Hepatitis B prophylaxis with immunoglobulin and/or vaccination was provided 
for 119 (60%) victims who had not completed vaccination. Emergency 
contraception was prescribed to 98/160 (61%) female victims. One woman who 
did not receive emergency contraception after having reported anal penetration 
only, eventually got pregnant, and her pregnancy resulted in miscarriage.  
 
 Of 160 SV episodes eligible for nPEP prescription, completion of the 28-
day course was achieved in 104 (65%, 95%CI 57-72%).   
 
Retention in care during the 180-day period was achieved for 89 episodes 
(45%, 95%CI 38-52%). None of the patients seronegative at baseline had 
seroconverted for HIV, HBV or hepatitis C infections at the 180th day follow-up 
assessment. Syphilis seroconversion was detected in a 10-year old girl, who 
inadvertently missed ceftriaxone prophylaxis. 
 
 
Predictors of adherence to nPEP  
 
In univariate analysis (Table 2), we found no statistically significant 
association between sex, age, race/ethnicity or schooling and adherence to nPEP. 
Likewise, type of perpetrator (known versus unknown), report of vaginal or anal 
penetration or of ejaculation at any anatomical site had no significant association 
with adherence to nPEP. Victims reporting oral penetration (n=43, 27%) were 
more likely to adhere to nPEP than those who did not report such an event 
(n=117, 73%), but this effect did not reach statistical significance (RR1.26, 
95%CI 1.02-1.58; p=0.059). Social support was associated with higher adherence 
(72% vs.47%, RR 1.52; 95%CI 0.93-2.47; p=0.03), as was having psychological 
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care after SV (RR 2.57; 95%CI 1.76-3.75; p<0.0001). SV victims reporting SV 
under the influence of alcohol or other substances were less likely to adhere to 




In a multivariate model including sex, age, alcohol or substance use, social 
support and psychological care, only psychological care retained statistically 
significant association with adherence to nPEP (adjusted OR 8.32; 95%CI 3.00-
23.03; p<0.001) (Table 2) 
 
Predictors of retention in care 
 
In univariate analysis of predictors of retention in care during 180 days 
after SV, we failed to find statistically significant associations with sex, age, 
race/ethnicity or schooling; penetration in oral cavity was associated with higher 
retention (RR 1.48; 95%CI 1.09-2.01; p=0.019)(Table 3).Report of vaginal or anal 
penetration and of ejaculation at any anatomical site had no significant 
association with this outcome. As seen in the analysis of predictors of adherence 
to nPEP, social support (RR 2.01; 95%CI 1.05-3.87, p=0.011) and psychological 
care (RR 3.89; 95%CI 2.22-6.81; p<0.001) were associated with higher retention. 
In contrast, lower retention was observed among patients with physical trauma 
at admission (RR 0.66; 95%CI 0.48-0.91; p=0.009) and those reporting SV under 





We fitted a multivariate model including sex, age, any cavity penetration, 
physical trauma, social support, psychological care and use of alcohol or other 
substances as covariates; as in the analysis of independent predictors of nPEP 
adherence, psychological care persisted as the only independent variable with 
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significant association with retention in care (adj OR 40.33, 95%CI 8.33-195.3, 




This is the first study to investigate predictors for adherence to nPEP and 
to retention in care for 180 days in a large cohort of SV victims presenting to 
emergency departments in Brazil. While adherence to nPEP for 28 days was 
relatively high (65%), only 45% of SV victims were retained in care over 180 
days, which is supposed to allow for full assessment of the efficacy of HIV/STI 
prophylaxis and promotion of health and well-being as well as deployment of 
social and economic interventions. Provision of psychological care and social 
support were both associated with higher adherence to nPEP and higher 
retention in care in univariate analysis, whereas alcohol/substance use prior to 
or during the SV episode was associated with both lower adherence and lower 
retention. However, only psychological care remained significantly associated 
with both outcomes in multivariate analysis. 
 
Knowledge of predictors of adherence to HIV prophylaxis and to retention 
in care for clinical and laboratory follow-up are useful in the context of SV since 
more resources can be allocated to those with higher likelihood of withdrawal. 
Psychological care is an invaluable tool for SV victims, not only due to its direct 
benefits for emotional welfare, but also as a strategy to improve adherence to 
medications and retention in care.  
Adherence to nPEP in our study was similar to that observed in previous 
reports from similar Brazilian environments up to 201017-19. Likewise, a 
systematic review and meta-analysis study showed that the overall adherence to 
PEP in the context of occupational exposure rarely exceeds 60%21. Moreover, 
two meta-analyses on nPEP after SV compared adherence between developed 
and developing countries17,22  and reported an overall low adherence to nPEP 
(40.32%) among SV victims, although adherence was markedly higher in 
developing countries than developed ones (53.20% vs 33.27%). Authors 
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hypothesized that the lower risk of HIV infection in developed countries could be 
a potential driver of lower prescription and adherence to nPEP17,22. It is also 
plausible that the availability of specialized SV units and access to nPEP free of 
charge in some countries, such as Brazil, might also contribute to higher 
adherence in contrast with others where nPEP depends on payment by the 
victim or on forensic evidence of SV (e.g.US, Canada;)23. However, a clear-cut 
association between provision of health services to SV victims and adherence to 
nPEP is still lacking. In Kenya, for instance, Muriuki et al.24 recently reported an 
overall adherence of 34% to nPEP for 28 days even though antiretroviral were 
provided free of charge as part of gender-based violence services. In fact, 
barriers to care, such as the requirement of a police report or forensic 
examination prior to hospital admission, may also hinder SV victims from 
seeking health care25,26.  
 
Several additional barriers have been described to impair full adherence 
to nPEP and retention to clinical follow-up after SV. These include factors related 
to the victims (lack of affordability in case antiretrovirals are not provided for 
free, drug side effects, emotional barriers, fear of aggressors), as well as 
structural barriers (lack of public policies and protective services, unavailability 
of skilled multidisciplinary team support27-29). Moreover, the way nPEP is 
prescribed may also affect this outcome. According to a systematic review, 
provision of a medication start pack does not improve adherence to nPEP24,30. In 
contrast, qualitative research has shown that inclusion of antiemetic and 
analgesic drugs in the prescription is beneficial, especially in the first 14 days to 
reduce the impact of medication side effects, thus contributing to enhance 
adherence to nPEP31. 
 
Overall, nPEP was highly accepted by our patients, except for 3 (1.8%) 
victims. Refusal to take antiretroviral drugs has been reported to occur in up to 
14% of patients, but this rate varies depending on the mode of HIV exposure21. 
Digestive complaints were the most common nPEP adverse effects in our cohort, 




Retention in care among SV victims has been previously reported as poor, 
ranging from 11 to 34.8%19,32 . However, innovative strategies such as a 
proactive follow-up protocol carried out in South Africa were able to enhance 
adherence to nPEP to 74% and retention in care to 81%33. The protocol included 
financial incentives for food and transportation and home visits, with victims 
receiving phone calls prior to follow-up visits and after missed appointments33.  
 
 Alcohol/substance use prior to or during the SV episode has been 
reported to occur in 28 to 60% of cases25,26 and is considered a relevant 
component of rape tactics25. In our study, it was reported by only 26 (16%) 
victims aged over 14 and was associated with lower adherence to nPEP and with 
lower retention in care in univariate analysis. However, such an association 
could not be demonstrated in our multivariate analysis. Our inclusion criteria 
(admission within 72h after the SV episode) may have contributed to reduce the 
number of alcohol/substance-related SV victims in the cohort. Recognition of the 
SV episode by the victim has been shown a predictor for seeking medical care 
and victims of alcohol/substance-related SV are known to be more likely to 
experience self-blame or to deny the incident34,35 . In fact, others25,26  have 
highlighted that these individuals are less likely to seek medical care and report 
to the police after an SV episode.  
  
 Victims of substance-related SV have also been shown to exhibit a higher 
risk of continuing or increasing alcohol abuse after the SV incident, which poses 
additional challenges for their retention in care25,34. Further studies are thus 
warranted to clarify whether exposure to alcohol/substance prior or during SV 
delays seeking medical care in the Brazilian context. 
 
 Given that 39% to 70% of SV victims develop post-traumatic stress 
syndrome (PTSS), potential benefits of psychological care after SV are expected8,9 
36,37. Cognitive behavior therapy seems to be more effective for adult SV women 
victims but for children and adolescents more studies are required9,36,37. Indeed, 
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psychotherapy has been shown to reduce PTSS symptoms when applied early 
after SV in conflict areas38. This could be because acute stress disorder is 
recognized as a predictor of PTSS after SV37. In our study, we showed that 
provision of psychological care was an essential element in the management of 
SV, being associated with enhanced adherence to both nPEP and retention in 
care. However, we cannot rule out the existence of unmeasured confounders; for 
example, patients undergoing at least one psychological appointment may have 
better overall engagement with care.  
 As far as the methodological approach is concerned, it is important to 
recognize that our single site retrospective cohort study was based on chart 
review of patient’s or tutor’s reports, in the absence of forensic evaluation. 
Despite the importance of our specialized center in the metropolitan area of Sao 
Paulo, generalization of our results is limited. 
 
Despite these limitations, the relevance of implementing effective services 
to respond to the complex needs of SV victims in all settings, including 
psychological care is unquestionable. In this context, identifying predictors of 
better outcomes and understanding how to overcome barriers to completion of 
guidelines may help healthcare providers improve quality of care for SV victims 
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Figure 1: Sexual violence episodes in victims admitted at Hospital das 









Table 1: Demographic characteristics of 199 sexual violence victims at 










Number of patients 199(100) 160 (80) 39(20) 
Age (median, IQR) 
    ≤13 years old (%) 
    14-17 years old (%) 














    Caucasian (%) 
    Black/Mixed (%) 




















    Unemployed 
    Student 
    Unskilled labor 
    Skilled labor 



















Mental or physical 
disability 





Table 2: Univariate and multivariate analysis for predictors of adherence 
to HIV post-exposure prophylaxis (nPEP) among sexual violence victims, 
Hospital das Clinicas, São Paulo, Brazil, 2001-2013. 
 
*reference category: non-caucasian; #includes family, friends and colleagues. 
 
  
 Univariate analysis Multivariate analysis 
Predictors RR 95% CI p-value 
Adjusted 
OR 
95% CI p-value 
Male sex 0.99 0.74-1.32 0.950 0.92 0.31-2.71 0.880 
Age (for each 10-year 
increase) 
1.03 0.96-1.11 0.392 1.01 0.71-1.42 0.976 
Caucasian race*  1.02 0.78-1.35 0.874    
Schooling (per year 
increase) 
1.00 0.98-1.01 0.532    
Known perpetrator 0.81 0.57-1.15 0.180    
Oral penetration 1.26 1.02-1.58 0.059    
Vaginal penetration 0.95 0.69-1.30 0.745    
Anal penetration 1.19 0.95-1.49 0.138    
Ejaculation (any 
anatomical site) 
1.02 0.78-1.32 0.875    
Social support# 1.52 0.93-2.47 0.036 1.41 0.40-4.99 0.598 
Psychological care 2.57 1.76-3.75 <0.001 8.32 3.00-23.03 <0.001 
Alcohol/substance use at 
the time of SV 
0.68 0.46-1.02 0.030 1.29 0.41-4.06 0.659 
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Table 3: Univariate and multivariate analysis for predictors of retention in 
care for 180 days among sexual violence victims. Hospital das Clinicas, São 
Paulo, Brazil, 2001-2013. 
 
*reference category: non-caucasian; #includes family, friends and colleagues. 
 
 Univariate analysis Multivariate analysis 




Male sex 1.04 0.71-1.52 0.841 0.90 0.65-1.24 0.502 
Age (for each 10-year 
increase) 
0.99 0.88-1.11 0.860 0.89 0.26-3.1 0.855 
Caucasian race* 1.32 0.88-1.99 0.152    
Schooling (per year 
increase) 
1.00 0.71-1.31 0.813    
Oral penetration 1.48 1.09-2.01 0.019    
Vaginal penetration 1.03 0.70-1.52 0.885    
Anal penetration 1.10 0.80-1.52 0.558    
Penetration(any)    1.04 0.25-4.5 0.952 
Ejaculation (any 
anatomical site) 
1.09 0.78-1.52 0.623    
Social support# 2.01 1.05-3.87 0.011 1.53 0.36-6.44 0.565 
Psychological care 3.89 2.22-6.81 <0.001 40.33 8.33-195.3 <0.001 
Physical trauma  0.66 0.48-0.91 0.009 0.45 0.18-1.14 0.092 
Alcohol/substance use at 
the time of SV 
0.45 0.24-0.85 0.003 0.69 0.64-2.90 0.613 
